$2.57
0.062.39%
At Close: -
$2.58
0.010.39%
After Hours: 4:43 PM EDT
15 minutes delayed
G1 Therapeutics
GTHXNASDAQ
G1 Therapeutics (NASDAQ:GTHX) Stock, Insider Trading Activity
G1 Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
4.520M
Institutional Percentage Held
8.65%
| Jul 08, 2024 | Andrew Perry | CHIEF COMMERCIAL OFFICER | -1.337K | $2.51 | -$3.35K | SELL | -1.17% | 112.614K | Jul 05 | View |
| Jul 08, 2024 | TERRY MURDOCK | CHIEF OPERATING OFFICER | -2.475K | $2.51 | -$6.21K | SELL | -1.90% | 128.012K | Jul 05 | View |
| Jul 08, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | -2.475K | $2.51 | -$6.21K | SELL | -1.53% | 159.312K | Jul 05 | View |
| Jul 08, 2024 | Mark Avagliano | CHIEF BUSINESS OFFICER | -2.638K | $2.51 | -$6.62K | SELL | -1.08% | 242.045K | Jul 05 | View |
| Jul 08, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | -527 | $2.51 | -$1.32K | SELL | -0.28% | 187.718K | Jul 05 | View |
| Jul 08, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | -7.662K | $2.51 | -$19.21K | SELL | -1.37% | 549.674K | Jul 05 | View |
| May 24, 2024 | Monica Thomas | CHIEF LEGAL & PEOPLE OFFICER | -5.826K | $4.27 | -$24.86K | SELL | -5.04% | 109.825K | May 23 | View |
| May 15, 2024 | Andrew Perry | CHIEF COMMERCIAL OFFICER | -8.151K | $4.79 | -$39.03K | SELL | -9.36% | 78.951K | May 13 | View |
| May 15, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | -8.151K | $4.79 | -$39.03K | SELL | -5.05% | 153.245K | May 13 | View |
| May 15, 2024 | TERRY MURDOCK | CHIEF OPERATING OFFICER | -8.151K | $4.79 | -$39.03K | SELL | -7.86% | 95.487K | May 13 | View |
| May 15, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | -8.151K | $4.79 | -$39.03K | SELL | -4.80% | 161.787K | May 13 | View |
| May 15, 2024 | Mark Avagliano | CHIEF BUSINESS OFFICER | -8.151K | $4.79 | -$39.03K | SELL | -3.74% | 209.683K | May 13 | View |
| May 15, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | -37.258K | $4.79 | -$178.42K | SELL | -7.61% | 452.336K | May 13 | View |
| Mar 20, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | -6.547K | $3.02 | -$19.75K | SELL | -5.02% | 123.896K | Mar 18 | View |
| Feb 13, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $2.46 | -$123.56K | SELL-OPTIONS | 0.00% | 169.938K | Feb 12 | View |
| Jan 08, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | 36.557K | $3.09 | -$2.30K | GRANT | 38.94% | 130.443K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | 33.56K | $3.08 | -$11.54K | GRANT | 24.61% | 169.938K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | Andrew Perry | CHIEF COMMERCIAL OFFICER | 31.157K | $3.12 | -$7.53K | GRANT | 55.69% | 87.102K | Jan 03 | View |
| Jan 08, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | 89.014K | $3.12 | -$36.45K | GRANT | 22.22% | 489.594K | Jan 03 | View |
| Jan 08, 2024 | Mark Avagliano | CHIEF BUSINESS OFFICER | 40.679K | $3.09 | -$12.60K | GRANT | 52.72% | 117.834K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | TERRY MURDOCK | CHIEF OPERATING OFFICER | 33.56K | $3.08 | -$11.54K | GRANT | 47.89% | 103.638K | Jan 03 - Jan 04 | View |
| Jan 02, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | -32.983K | $3.27 | -$108.01K | SELL | -7.61% | 400.58K | Jan 02 | View |
| Dec 13, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $1.89 | -$103.44K | SELL-OPTIONS | 0.00% | 136.378K | Dec 11 | View |
| Aug 10, 2023 | Mark Velleca | — | 0 | $1.19 | -$96.82K | SELL-OPTIONS | 0.00% | 116K | Aug 08 | View |
| Jul 07, 2023 | Andrew Perry | CHIEF COMMERCIAL OFFICER | -355 | $2.45 | -$871.06 | SELL | -0.63% | 55.945K | Jul 05 | View |
| Jul 07, 2023 | TERRY MURDOCK | CHIEF OPERATING OFFICER | -1.361K | $2.45 | -$3.34K | SELL | -1.91% | 70.078K | Jul 05 | View |
| Jul 07, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | -1.361K | $2.45 | -$3.34K | SELL | -0.99% | 136.378K | Jul 05 | View |
| Jul 07, 2023 | Jack John Bailey Jr | PRESIDENT AND CEO | -2.719K | $2.45 | -$6.67K | SELL | -0.62% | 433.563K | Jul 05 | View |
| Jan 05, 2023 | Jennifer Moses | CFO | 19.932K | $5.52 | -$13.08K | GRANT | 52.61% | 57.82K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | TERRY MURDOCK | CHIEF OPERATING OFFICER | 15.532K | $5.52 | -$13.08K | GRANT | 74.29% | 36.439K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | Andrew Perry | CHIEF COMMERCIAL OFFICER | 15.28K | $5.58 | -$4.57K | GRANT | 253.82% | 21.3K | Jan 03 - Jan 04 | View |
| Jan 05, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | 15.532K | $5.52 | -$13.08K | GRANT | 17.81% | 102.739K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | James S Hanson | GENERAL COUNSEL | 15.532K | $5.52 | -$13.08K | GRANT | 60.78% | 41.087K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | Jack John Bailey Jr | PRESIDENT AND CEO | 43.074K | $5.81 | -$218.71K | GRANT | 18.47% | 276.282K | Jan 03 - Jan 04 | View |
| Oct 20, 2022 | Mark Velleca | — | 0 | $6.04 | -$169.64K | SELL-OPTIONS | 0.00% | 116K | Oct 18 | View |
| Sep 22, 2022 | Mark Velleca | — | 0 | $6.95 | -$262.24K | SELL-OPTIONS | 0.00% | 116K | Sep 20 | View |
| Sep 16, 2022 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $8.05 | -$275.73K | SELL-OPTIONS | 0.00% | 73.207K | Sep 13 | View |
| Aug 18, 2022 | Mark Velleca | — | 0 | $6.51 | -$979.70K | SELL-OPTIONS | 0.00% | 116K | Aug 16 | View |
| Jul 06, 2022 | TERRY MURDOCK | CHIEF OPERATING OFFICER | -648 | $5.17 | -$3.35K | SELL | -3.01% | 20.907K | Jul 05 | View |
| Jul 06, 2022 | Rajesh Malik | CHIEF MEDICAL OFFICER | -648 | $5.17 | -$3.35K | SELL | -0.88% | 73.207K | Jul 05 | View |
| Jan 05, 2022 | James S Hanson | GENERAL COUNSEL | 10.555K | $10.61 | -$15.33K | GRANT | 70.37% | 25.555K | Jan 03 - Jan 05 | View |
| Jan 05, 2022 | TERRY MURDOCK | CHIEF OPERATING OFFICER | 10.555K | $10.61 | -$15.33K | GRANT | 95.95% | 21.555K | Jan 03 - Jan 05 | View |
| Jan 05, 2022 | Jennifer Moses | CFO | 10.555K | $10.61 | -$15.33K | GRANT | 42.22% | 35.555K | Jan 03 - Jan 05 | View |
| Jan 05, 2022 | Rajesh Malik | CHIEF MEDICAL OFFICER | 10.555K | $10.61 | -$15.33K | GRANT | 19.80% | 63.855K | Jan 03 - Jan 05 | View |
| Jan 05, 2022 | Mark Avagliano | CHIEF BUSINESS OFFICER | 10.555K | $10.61 | -$15.33K | GRANT | 95.95% | 21.555K | Jan 03 - Jan 05 | View |
| Jan 05, 2022 | Jack John Bailey Jr | PRESIDENT AND CEO | 11.875K | $10.41 | -$355.26K | GRANT | 5.37% | 233.208K | Jan 03 | View |
| Jul 15, 2021 | Mark Velleca | — | 0 | $9.70 | -$558.56K | SELL-OPTIONS | 0.00% | 61K | Jul 13 - Jul 15 | View |
| Jun 30, 2021 | SETH RUDNICK | — | 0 | $11.36 | -$219.76K | SELL-OPTIONS | 0.00% | 9.655K | Jun 29 | View |
| Jun 17, 2021 | Mark Velleca | — | 0 | $11.18 | -$647.32K | SELL-OPTIONS | 0.00% | 61K | Jun 15 - Jun 17 | View |
| May 13, 2021 | Mark Velleca | — | 0 | $10.15 | -$585.40K | SELL-OPTIONS | 0.00% | 41K | May 11 - May 13 | View |
| Apr 23, 2021 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $11.23 | -$325.25K | SELL-OPTIONS | 0.00% | 43.3K | Apr 22 | View |
| Apr 15, 2021 | Mark Velleca | — | 0 | $12.42 | -$722.07K | SELL-OPTIONS | 0.00% | 41K | Apr 13 - Apr 15 | View |
| Mar 24, 2021 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $11.16 | -$323.21K | SELL-OPTIONS | 0.00% | 43.3K | Mar 23 | View |
| Mar 04, 2021 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $12.25 | -$320.97K | SELL-OPTIONS | 0.00% | 43.3K | Mar 02 | View |
| Feb 18, 2021 | Mark Velleca | — | 0 | $16.76 | -$809.77K | SELL-OPTIONS | 0.00% | 41K | Feb 16 - Feb 18 | View |
| Jan 22, 2021 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $12.40 | -$247.04K | SELL-OPTIONS | 0.00% | 40.2K | Jan 22 | View |
| Jan 21, 2021 | Mark Velleca | — | 4K | $12.17 | -$517.13K | SELL-OPTIONS | 10.81% | 41K | Jan 19 - Jan 21 | View |
| Dec 29, 2020 | SETH RUDNICK | — | -924 | $20.10 | -$18.57K | SELL | -14.93% | 5.266K | Dec 24 | View |
| Dec 23, 2020 | SETH RUDNICK | — | -32.092K | $20.27 | -$650.46K | SELL | -83.83% | 6.19K | Dec 22 - Dec 23 | View |
| Dec 17, 2020 | Mark Velleca | — | 0 | $11.63 | -$474.39K | OPTION EXERCISE | 0.00% | 37K | Dec 15 - Dec 17 | View |
| Dec 11, 2020 | Rajesh Malik | — | 0 | $12.12 | -$143.02K | OPTION EXERCISE | 0.00% | 29.2K | Dec 10 | View |
| Dec 10, 2020 | SETH RUDNICK | — | -19.48K | $20.22 | -$393.90K | SELL | -33.72% | 38.282K | Dec 08 - Dec 10 | View |
| Dec 03, 2020 | SETH RUDNICK | — | -520 | $20.09 | -$10.45K | SELL | -0.89% | 57.762K | Dec 01 | View |
| Nov 19, 2020 | GLENN MUIR | — | 50K | $13.50 | $675.00K | PURCHASE | 41.33% | 170.969K | Nov 18 | View |
| Nov 13, 2020 | Jack John Bailey Jr | — | 8K | $12.80 | $102.37K | PURCHASE | ∞ | 8K | Nov 10 - Nov 11 | View |
| Sep 08, 2020 | James S Hanson | — | 1K | $14.95 | $14.95K | PURCHASE | 33.33% | 4K | Sep 04 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.